In a recent business update, PERFECT MEDICAL (HKEX: 01830) announced a 12.1% year-on-year increase in sales contract value for the three-month period ended June 30, 2026.
The company attributed this growth primarily to the robust momentum of the broader economic recovery.
Looking ahead, the group expressed sustained optimism regarding its business performance. It stated its commitment to continue delivering high-quality services and enhancing operational efficiency.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments